On Aug. 27, 2026, New Mexico Attorney General Raúl Torrez sued the U.S. Department of Justice and Attorney General Todd Blanche.
The case was filed in the U.S. District Court for the District of New Mexico to obtain DEA fentanyl-handling records, according to the state announcement. At issue is alleged "fentanyl walking." The state uses that term for federal agents letting drug shipments proceed to target higher-level traffickers, as described by the Los Alamos Reporter in its account republishing the state release. The complaint frames New Mexico families and communities statewide as the affected population.
Table of Contents
- Why did New Mexico go to court?
- What did agents allegedly allow?
- Who does the state say was harmed?
- Can residents file a claim now?
Why did New Mexico go to court?
New Mexico sought internal policies, investigative files, communications, whistleblower-disclosure records, and public-health impact information in July 2026. The state says it supplied added information after the first request.
The Justice Department denied the request and produced nothing. The new suit asks a federal court to order access under the Administrative Procedure Act and to protect state investigative authority.
What did agents allegedly allow?
The state investigation followed whistleblower allegations covering 2022 to 2025. Agents allegedly let shipments proceed to pursue higher-level traffickers in possible violation of federal fentanyl protocols.
A separate account summarizing Associated Press reporting found agents monitored large fentanyl quantities in New Mexico from 2023 through 2025 without seizure, as detailed in this account summarizing Associated Press reporting. Whistleblowers said agents were ordered to stand down while hundreds of thousands of pills moved despite rules requiring prompt confiscation.
Who does the state say was harmed?
The complaint cites a 21% increase in overdose deaths in New Mexico during the period investigated. It contrasts that rise with a 14% national decline in overdose deaths.
New Mexico's House delegation said June 25, 2026 that whistleblower reports indicated hundreds of thousands of deadly fentanyl pills may have reached state streets over several years. The delegation asked House Oversight and Judiciary leaders for public hearings and investigation, according to the June 25 statement from Rep. Melanie Stansbury.
Can residents file a claim now?
No claim form, settlement fund, or eligibility process exists under this lawsuit. The case seeks records access, not a liability ruling against the Justice Department or DEA.
That limit matters for families seeking compensation. The filing alone does not prove DEA conduct caused specific overdoses. Outcome depends on court action and pending reviews, including a House Oversight records demand and a Justice Department inspector general review of how widely the track-without-seizing tactic was used.
- Track the federal court case in the District of New Mexico for orders on records release
- Watch House Oversight for hearings and released DEA records
- Watch the inspector general review for findings on nationwide use
- Keep medical, pharmacy, treatment, and expense records in a personal file if a later case opens
You Might Also Like
- Justice Department sues Ohio landlord over sexual harassment of female tenants
- Trump Administration Sues Arizona Over In-State Tuition for Dreamers
- Pennsylvania Attorney General Sues Snapchat Over Child Safety